Abstract
An acute infection with hepatitis E virus (HEV) genotype 3 subtype c was diagnosed in a patient with chronic lymphatic B-cell leukemia 6 weeks after the infusion of donor lymphocytes. Despite intensive care the patient died 39 days after admission due to pericardial effusion that was related to acute liver failure. We suggest that diagnostic procedures for detection of HEV infection should be seriously considered for the immunocompromised patient with elevated liver enzymes in the absence of a travel history to HEV endemic countries.
Similar content being viewed by others
References
Bächlein C, Grummer B. Hepatitis E—a new zoonotic disease in Germany? Berl Munch Tierarztl Wochenschr. 2010;123:198–204.
Frickmann H, Gabriel M, Polywka S, Bonow I, Günther S, Schmidt-Chanasit J. An unusual cause of elevated liver function tests in an elderly female. J Clin Virol. 2011;51:93–5. doi:10.1016/j.jcv.2011.02.012.
Pischke S, Potthoff A, Hauröder B, Schlué J, Manns MP, Cornberg M, et al. Hepatitis E virus infection: a paradigm shift? Dtsch Med Wochenschr. 2010;135:1129–33.
Péron JM, Bureau C, Poirson H, Mansuy JM, Alric L, Selves J, et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat. 2007;14:298–303.
Tamura A, Shimizu YK, Tanaka T, Kuroda K, Arakawa Y, Takahashi K, et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res. 2007;37:113–20.
Johne R, Plenge-Bönig A, Hess M, Ulrich RG, Reetz J, Schielke A. Detection of a novel hepatitis E-like virus in faeces of wild rats using a nested broad spectrum RT-PCR. J Gen Virol. 2010;91:750–8.
Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol. 2006;16:5–36.
Aggarwal R, Naik S. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol. 2009;24:1484–93.
Boxall E, Herborn A, Kochethu G, Pratt G, Adams D, Ijaz S, et al. Transfusion-transmitted hepatitis E in a ‘nonhyperendemic’ country. Transfus Med. 2006;16:79–83.
Lee CK, Chau TN, Lim W, Tsoi WC, Lai ST, Lin CK. Prevention of transfusion-transmitted hepatitis E by donor-initiated self exclusion. Transfus Med. 2005;15:133–5.
Matsubayashi K, Nagaoka Y, Sakata H, Sato S, Fukai K, Kato T, et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion. 2004;44:934–40.
Mitsui T, Tsukamoto Y, Yamazaki C, Masuko K, Tsuda F, Takahashi M, et al. Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion. J Med Virol. 2004;74:563–72.
Adlhoch C, Wolf A, Meisel H, Kaiser M, Ellerbrock H, Pauli G. High HEV prevalence in four different wild boar populations in East and West Germany. Vet Microbiol. 2009;139:270–8. doi:10.1016/j.vetmic.2009.06.032.
Ayoola EA, Want MA, Gadour MO, Al-Hazmi MsH, Hamza MK. Hepatitis E virus infection in haemodialysis patients: a case-control study in Saudi Arabia. J Med Virol. 2002;66:329–34.
Hosseini-Moghaddam SM, Zarei A, Alavian SM, Mansouri M. Hepatitis E virus infection: a general review with a focus on hemodialysis and kidney transplant patients. Am J Nephrol. 2010;31:398–407.
Myint KS, Gibbons RV. Hepatitis E: a neglected threat. Trans R Soc Trop Med Hyg. 2008;102:211–2.
Kamar N, Rostaing L, Abravanel F, Garrouste C, Lhomme S, Esposito L, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology. 2010;139:1612–8.
Mumtaz K, Azam Z, Hamid S, Abid S, Memon S, Ali Shah H, et al. Role of N-acetylcysteine in adults with non-acetaminophen-induced acute liver failure in a center without the facility of liver transplantation. Hepatol Int 2009;3:563–70.
Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet. 2010;376:895–902.
Acknowledgments
We acknowledge Petra Emmerich for helpful discussions and Insa Bonow, Marzena Domagalski, Alexandra Bialonski and Deborah Maus for technical assistance. The experiments comply with the current laws of Germany.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Susanne Pfefferle and Hagen Frickmann contributed equally to this article.
Rights and permissions
About this article
Cite this article
Pfefferle, S., Frickmann, H., Gabriel, M. et al. Fatal course of an autochthonous hepatitis E virus infection in a patient with leukemia in Germany. Infection 40, 451–454 (2012). https://doi.org/10.1007/s15010-011-0220-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-011-0220-7